id_pmc	sentence location	highlighted phrase	protein entities found	number of protein entities
2648874	body	Twenty|mutation|include|L10F|/|R|,|K20T|,|L23I|,|K43T|,|M46L|,|G48M|,|F53Y|,|Q58E|,|V71I|/|L|,|T74P|,|L76V|,|V82C|/|L|,|N83D|,|I85V|,|L89V|/|T|,|and|I93M|be|not|on|the|2007|SDRM|list|.	L10F|R|L23I|M46L|G48M|Q58E|V71I|T74P|L76V|V82C|N83D|I85V|L89V|I93M	14
2648874	body	Ten|mutation|be|not|add|because|they|occur|at|polymorphic|position|(|L10F|/|R|,|K20T|,|K43T|,|V71I|/|L|,|T74P|,|L89V|/|T|,|and|I93M|)|.	L10F|R|V71I|T74P|L89V|I93M	6
7925099	body	As|indicate|in|the|box|legend|,|which|apply|to|both|panel|,|cyclophilin|A|binding|loop|mutation|that|have|be|previously|identify|as|tissue|culture|adaptation|be|mark|with|a|dagger|symbol|,|and|previously|describe|nelfinavir|-|specific|mutation|be|mark|with|an|asterisk|(|with|all|reference|for|these|in|the|text|and|Table|1|and|2|)|.A|would|be|expect|,|we|observe|that|37|passage|in|the|presence|of|nelfinavir|lead|to|the|emergence|of|three|well|know|resistance|mutation|in|HIV|-|1|protease|:|L10F|,|V77I|,|and|L90M|(|indicate|in|red|in|Fig|.	cyclophilin|A|Tables|1|and|2|HIV|-|1|protease|L10F|V77I|L90M	13
7925099	body	8B|use|HXB2|genome|numbering|;|Table|1|)|,|with|L90M|be|a|primary|resistance|mutation|and|V77I|and|L10F|be|common|secondary|mutation|that|further|boost|nelfinavir|resistance|(|42â€“46|)|.	8B|HXB2|L90M|V77I|L10F	5
7925099	body	L10F|be|detect|later|,|become|dominant|at|passage|37|.	L10F	1
7120516	body	Associate|with|resistance|to|most|nucleoside|analogue|except|lamivudineM41L|,|D67NIn|vitro|cause|high|-|level|resistance|to|zidovudine|and|low|-|level|resistance|to|stavudine|,|didanosine|,|and|abacavirK70R|,|L210WSegregate|in|two|pathway|,|one|comprising|T215Y|and|L210W|and|the|other|T215F|and|K219QT215Y|,|T215F|,|K219Q|,|K219EPathway|comprising|T215Y|and|L210W|associate|with|decrease|responsiveness|to|tenofovirM184VObserve|in|most|virus|resistant|to|treatment|with|lamivudineConfer|high|-|level|resistance|to|lamivudine|in|vitroCan|interfere|with|resistance|to|zidovudine|and|stavudine|when|the|number|of|thymidine|analogue|mutation|be|smallIncrease|the|level|of|resistance|to|didanosine|and|abacavir|owe|to|thymidine|analogue|mutationsQ151MRare|pathway|for|resistance|of|HIV|-|1|to|nucleoside|analoguesF116Y|,|F77L|,|V75I|,|A62VIn|vitro|,|cause|high|-|level|resistance|to|most|nucleoside|analogue|except|lamivudine|and|tenofovir69|Insertional|mutationsInsertion|of|two|or|more|amino|acid|(|usually|serine|)|next|to|codon|69Emerge|only|in|virus|that|already|have|several|thymidine|analogue|mutationsConfer|high|-|level|resistance|to|all|nucleoside|analoguesK65RSelecte|for|by|zalcitabine|,|abacavir|,|and|tenofovir|therapyY115FSelecte|for|by|abacavir|therapyL74VSelecte|for|by|didanosine|therapy|,|usually|when|didanosine|be|the|only|nucleoside|analogueMutation|confer|resistance|to|NNRTIsK103NMutation|most|frequently|select|for|by|efavirenz|therapyOccasionally|select|for|by|nevirapine|therapyConfer|high|-|level|resistance|to|all|available|NNRTIsY181CMutation|most|frequently|select|by|nevirapineY188CConfer|high|-|level|resistance|to|nevirapine|but|low|-|level|resistance|to|efavirenzY108IY188L|,|unlike|Y188C|,|see|mostly|with|efavirenz|therapyL100I|,|V106A|,|G190A|,|G190SMutation|that|accumulate|during|prolonged|ineffective|therapy|with|most|NNRTIsProtease|and|gag|mutationsL90MFrequent|resistance|mutation|,|observe|during|failure|of|therapy|with|most|protease|inhibitorsMutation|most|frequently|select|for|by|saquinavir|therapyV82A|,|V82T|,|V82FCommon|resistance|mutationsCan|emerge|early|during|failure|of|therapy|with|most|protease|inhibitorsMutation|most|frequently|select|for|by|ritonavir|and|indinavir|therapyD30NMutation|most|frequently|select|for|by|nelfinavir|therapyN88D|,|N88SD30N|always|firstL101|,|L10F|,|K20R|,|K20M|,|M36I|,|M46I|,|M46L|,|Mutation|that|can|accumulate|during|failure|of|therapy|with|most|protease|inhibitor|,|cause|gradual|increase|in|the|level|of|resistanceI54V|,|I54L|,|A71V|,|A71T|,|G73S|,|V77I|,|M93LI84VFrequently|find|after|prolonged|ineffective|therapy|with|protease|inhibitorsAssociate|with|high|-|level|resistance|to|most|protease|inhibitorsG48VExclusively|select|for|by|saquinavir|therapyAssociate|with|high|-|level|resistance|to|saquinavirL24IEmerge|occasionally|during|failure|of|indinavir|therapyAlso|find|with|lopinavir|therapyI47V|,|I50VMost|often|select|for|by|amprenavir|therapyAlso|find|with|lopinavir|therapyV32I|,|F53LRare|mutationsConfer|high|-|level|resistance|to|most|protease|inhibitorsA431VMutation|in|gag|,|the|main|viral|substrate|of|the|proteaseL449FIncreas|resistance|and|partially|compensate|for|resistance|-|associate|loss|of|viral|replicative|capacityMutation|be|designate|accord|to|the|letter|of|the|wild|-|type|amino|acid|that|be|subject|to|substitution|,|follow|in|turn|by|the|position|of|that|amino|acid|in|the|reverse|transcriptase|or|protease|sequence|and|by|the|letter|of|the|mutant|amino|acid|.	L210W|T215F|T215F|L210W|F77L|V75I|V106A|G190A|NNRTIsProtease|V82T|N88SD30N|always|firstL101|L10F|K20R|K20M|M36I|M46I|M46L|I54L|A71V|A71T|G73S|V77I|protease|protease|wild|-|type|amino|acid|reverse|transcriptase|mutant|amino|acid	36
7605711	body	7|mutant|be|L10F|,|I47V|,|T74P|,|L76V|,|V82F|,|V82T|,|L90M|.	L10F|I47V|T74P|L76V|V82F|V82T|L90M	7
16122817	abstract	At|the|end|of|the|selection|experiment|,|virus|harbour|10|mutation|in|the|protease|(|L10F|,|I13V|,|V32I|,|L33F|,|M36I|,|K45I|,|I54V|,|A71V|,|V82L|,|I84V|)|as|well|as|a|mutation|in|the|CA|/|SP1|gag|cleavage|site|be|select|and|show|87|-|fold|decrease|susceptibility|to|tipranavir|.	protease|L10F|I13V|V32I|L33F|M36I|I54V|A71V|V82L|SP1	10
